12 posts
Health Nation asked Dr. Nikhil Palekar, M.D., questions about the Alzheimer’s biomarker screening test, cognitive and neurocognitive tests, what specialists you should see if you are experiencing memory issues and more. Here's what to know about tests for Alzheimer's and other forms of dementia.
Nancy Chandler had recently moved back to Long Island, N.Y., and noticed a change in her mother. She was much more anxious, became easily overwhelmed, and kept repeating herself.
John Chandler is a resident of Long Island, New York. The text below is excerpted from a longer audio podcast previously posted with The Alzheimer’s Association Podcast series, "Life After Diagnosis: a Conversation on Living Well."
A long-time volunteer with the Alzheimer's Association, Chandler is working to raise awareness on dementia research, funding and treatment outcomes.
Speaking with Dr. Margarita Reyes of Bristol Health in Connecticut about cultural health considerations, the stages of grief after a diagnosis; how to handle misconceptions or misinformation; or when an individual is resistant to getting evaluated for Alzheimer’s or other forms of dementia.
My mother, Paulette, and my dad, Edwidge, came to America from Haiti in the ’70s. My mother was very well educated. She actually used to be a teacher in Haiti. We used to run into people who were her students all the time.
Cusido had a complicated relationship with her father who was often angry and volatile–even before he was diagnosed with Alzheimer’s disease. Towards the end of his life, Cusido became her father’s primary caretaker in his N.J. home.
African-Americans have higher rates of Alzheimer’s disease, and other forms of dementia. A significantly higher number of African-Americans are more likely to be diagnosed at a later stage of the disease. Far too many who are aging in place with dementia often face healthcare access issues.
A blood biomarker test for Alzheimer’s disease was approved by the Food and Drug Administration well over a year ago, in May 2025, but according to medical professionals and advocacy organizations like the Alzheimer’s Association, there is still a significant public knowledge gap.
